Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX) has announced it will release its first quarter 2025 financial results on Monday, May 12, 2025, before U.S. financial markets open. The company has stated that it will not host a conference call to discuss the results.

News Market Reaction

%

1 alert

% News Effect

On the day this news was published, TNGX declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report first quarter 2025 financial results on May 12, 2025, before the open of the U.S. financial markets. The company does not intend to hold a conference call.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.

Investors and Media:

Elizabeth Hickin
IR@tangotx.com
media@tangotx.com

FAQ

When will Tango Therapeutics (TNGX) report Q1 2025 earnings?

Tango Therapeutics will report its Q1 2025 financial results on Monday, May 12, 2025, before the U.S. financial markets open.

Will Tango Therapeutics (TNGX) hold an earnings call for Q1 2025 results?

No, Tango Therapeutics has stated that it does not intend to hold a conference call for the Q1 2025 earnings release.

What time will TNGX release its Q1 2025 earnings?

Tango Therapeutics will release its Q1 2025 earnings before the U.S. financial markets open on May 12, 2025.